Streetbeat News

Products Services

AAAU

Gold prices have shown slight gains as traders focus on U.S. economic reports, with gold remaining near $2650. The article hints at the potential mention of AAAU, a gold-related ETF.

Portfolio Pulse from

December 04, 2024 | 6:45 pm

CYTK

Cytokinetics has started enrollment for a phase III study, COMET-HF, to evaluate the efficacy of omecamtiv mecarbil in patients with symptomatic heart failure with severely reduced ejection fraction.

Portfolio Pulse from

December 04, 2024 | 6:45 pm

RDNT

Ketryx has been selected by DeepHealth, a subsidiary of RadNet, Inc., to enhance AI-powered health informatics solutions.

Portfolio Pulse from

December 04, 2024 | 6:45 pm

MRVL

Marvell Technology's stock surged over 20% following its third quarter earnings beat and positive guidance for the fourth quarter and full year, driven by strong AI demand forecasts.

Portfolio Pulse from

December 04, 2024 | 6:45 pm

LOGI

Logitech has partnered with Airdrop Gaming to sell the Audio Radar system, which enhances gaming experiences for deaf and auditory disabled individuals. This partnership could expand Logitech's market reach and product offerings.

Portfolio Pulse from

December 04, 2024 | 6:30 pm

WCC

WESCO International is focusing on digital transformation strategies and innovation programs as part of its tech activities for 2024. This is highlighted in a new company profile added to ResearchAndMarkets.com's offerings.

Portfolio Pulse from

December 04, 2024 | 6:30 pm

SRE

Sempra, a utility company with operations in California, Texas, and Port Arthur LNG projects, shows strong growth prospects despite recent earnings misses. The company reaffirmed its FY2024 and FY2025 guidance, making it a buy recommendation with a strategy to start small and add on dips.

Portfolio Pulse from

December 04, 2024 | 6:30 pm

PCRX

Pacira Pharmaceuticals (PCRX) has been granted a new patent by the U.S. Patent and Trademark Office for the chemical composition of its lead pain-management drug, Exparel.

Portfolio Pulse from

December 04, 2024 | 6:30 pm

ITCI

Intra-Cellular Therapies (ITCI) has submitted a supplemental New Drug Application (sNDA) to the FDA for the expanded use of Caplyta as an adjunctive therapy for Major Depressive Disorder (MDD) in adults. This move could potentially broaden the market for Caplyta if approved.

Portfolio Pulse from

December 04, 2024 | 6:15 pm

AMZN

Amazon Web Services (AWS) announced new innovations for Amazon Bedrock at AWS re:Invent, enhancing generative AI capabilities with over 100 new models and improved data handling. This move underscores AWS's commitment to AI model choice and scalable inference.

Portfolio Pulse from

December 04, 2024 | 6:15 pm